Post Operative PainNCT05920265
Quadratus Lumborum Plain Block Versus Fascia Iliac Block
A study testing Quadratus Lumborum plain Block and fascia iliaca block in people with Post Operative Pain, run by Minia University at 1 site in Egypt.
Trial summary
evaluation the efficacy of Quadratus Lumborum plain Block Versus Fascia Iliac Block for postoperative pain after hip surgery Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Post Operative Pain
- What is being tested?
- Quadratus Lumborum plain Block and fascia iliaca block
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Feb 2021to 1 Sep 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18-70 years
- fracture hip
Who cannot join
- patients refuse
- mental problem patient with any coagulation deficiency or bleeding problems patient with allergy to investigated medications,
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Quadratus Lumborum Plain Block Versus Fascia Iliac Block in Hip Fracture
evaluation the efficacy of Quadratus Lumborum plain Block Versus Fascia Iliac Block for postoperative pain after hip surgery
- Conditions
- Post Operative Pain
- Being tested
- Quadratus Lumborum plain Block, fascia iliaca block, control group
- Keywords
- QLB, Fascia Iliac Block, hip surgery
- Medical subject headings
- Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Quadratus Lumborum plain BlockProcedure or surgery
ultrasound guided Quadratus Lumborum plain Block using 0.5 ml/kg bupivacaine 0.25% .
fascia iliaca blockProcedure or surgery
ultrasound guided fascia iliaca block using 0.5 ml/kg bupivacaine 0.25%
control groupDiagnostic test
no intervention
| Study group | Role | What they receive |
|---|---|---|
| Quadratus Lumborum Block | Experimental | Not described Receives: Procedure: Quadratus Lumborum plain Block |
| Fascia Iliac Block | Experimental | Not described Receives: Procedure: fascia iliaca block |
| control | Active comparator | Not described Receives: Diagnostic Test: control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
analgesic consumption
intraoperative and post operative
Measured: 24 hour
Secondary outcomes (2)
Visual analogue pain score
score 0-10 which mean 0 no pain and 10 the worst pain
Measured: 24 hour
first analgesic demand
the first time to intake rescue analgesia
Measured: 24 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jun 2023
- Study start1 Feb 2021
- Primary completion15 Jun 2022
- Study completion1 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post Operative PainStudies of the same condition, open and under way.
- More trials run by Minia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Minia University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hassan Mokhtar Elshorbagy Hetta, Minia University
- Investigators
- abeer M hassaneen, Ass. professor, Study director, minia university hospital/ faculty of medicineahmed H Mohamed, Professor, Study chair, minia university hospital/ faculty of medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05920265
- Sponsor's protocol ID
- 16:2021
- Status last verified
- Jun 2023
- First submitted
- 16 Jun 2023
- Last updated
- 27 Jun 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Quadratus Lumborum Plain Block Versus Fascia Iliac Block in Hip Fracture
- ClinicalTrials.gov ID
- NCT05920265
- Acronym / sponsor ID
- 16:2021
- Conditions
- Post Operative Pain
- Keywords
- QLB, Fascia Iliac Block, hip surgery
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Minia UniversityUniversity, hospital or other
- Study start
- 1 Feb 2021 (actual)
- Primary completion
- 15 Jun 2022 (actual)
- Study completion
- 1 Sep 2022 (actual)
- First posted
- 27 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
evaluation the efficacy of Quadratus Lumborum plain Block Versus Fascia Iliac Block for postoperative pain after hip surgery
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Quadratus Lumborum Block | Experimental | Procedure: Quadratus Lumborum plain Block |
| Fascia Iliac Block | Experimental | Procedure: fascia iliaca block |
| control | Active comparator | Diagnostic Test: control group |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- 18-70 years
- fracture hip
Key exclusion criteria (2 listed)
- patients refuse
- mental problem patient with any coagulation deficiency or bleeding problems patient with allergy to investigated medications,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Quadratus Lumborum plain Blockultrasound guided Quadratus Lumborum plain Block using 0.5 ml/kg bupivacaine 0.25% . | Procedure or surgery | Quadratus Lumborum Block |
| fascia iliaca blockultrasound guided fascia iliaca block using 0.5 ml/kg bupivacaine 0.25% | Procedure or surgery | Fascia Iliac Block |
| control groupno intervention | Diagnostic test | control |
Primary outcome
analgesic consumption
Time frame: 24 hour
intraoperative and post operative
2 secondary outcomes
Visual analogue pain score
Time frame: 24 hour
first analgesic demand
Time frame: 24 hour
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Jun 2023.
- Individual participant dataSharing planned: No
Related trials for Post Operative Pain
RecruitingPhase 4
ESP Blocks for Posterior Spinal Fusion
Postoperative Pain
Recruiting
Effect of Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite on Post-Operative Endodontic Pain.
Symptomatic Irreversible Pulpitis, Symptomatic Apical Periodontitis
RecruitingPhase 2
REctus Sheath Trial
Acute Pain, Postoperative Pain, Acute
Not yet recruiting
Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain
Breast Cancer, Postoperative Pain
Active, not recruitingPhase 4
Effect of Dexmedetomidine on Postoperative Pain in Spinal Anesthesia for Cesarean Section at Assuit University Hospital
Cesarean Section
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
abeer M hassaneen, Ass. professor study director
minia university hospital/ faculty of medicine
ahmed H Mohamed, Professor study chair
minia university hospital/ faculty of medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Quadratus Lumborum plain Block and fascia iliaca block in people with Post Operative Pain, run by Minia University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
analgesic consumption (time frame: 24 hour). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2023.